Skip to content

Bilateral Priming for Upper Extremity Hemiparesis in Older Adults

A Comparison of Two Types of Priming for Upper Extremity Hemiparesis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02277028
Enrollment
16
Registered
2014-10-28
Start date
2014-04-01
Completion date
2016-04-30
Last updated
2023-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Upper Extremity Hemiparesis

Brief summary

This study will compare bilateral priming followed by task specific training to health care education followed by the same task specific training protocol. The intention is to understand the effects of priming on upper limb training post-stroke.

Detailed description

Techniques to enhance use dependent plasticity have been examined in stroke rehabilitation research. The purpose of these techniques is to prime the cortex prior to training. The priming techniques previously described in the literature include medication (i.e. amphetamines), transcranial electric or magnetic stimulation, and manipulation of somatosensory input. Here, the investigators examine a priming technique which is non-invasive and free of side effects. The technique described in this study uses bilateral, symmetrical, rhythmic movement bilateral priming and its purpose is to ready the motor cortex for functional limb training. A rocker is used so that the less affected limb can drive the affected one in symmetrical wrist flexion and extension. In this project, the investigators intend to compare bilateral upper limb priming with task specfiic training to a health care education website program followed by the same task specific training as the experimental group.This active comparator (health care education) will receive stroke related health education via a website from the American Heart Association. Transcranial Magnetic Stimulation willl include measurement of transcallosal inhibition persistence from the affected hemisphere to the less affected hemisphere and vice versa ( less affected to affected). The investigators expect the bilateral priming group to have greater changes in transcranial magnetic stimulation measures and greater improvements in behavioral measures at all time points.

Interventions

BEHAVIORALpriming and task specific training

This task specific training protocol has been used in several clinical trials.

Sponsors

Rush University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Must have survived a unilateral stroke at least six months prior to enrollment * Fugl Meyer Upper Extremity Score between 22-38.

Exclusion criteria

* No individuals who have a pacemaker, metal implant in head or neck, history of seizures, recent concussion or history of headaches

Design outcomes

Primary

MeasureTime frameDescription
Change Score of Chedoke Arm and Hand Activity Index Nine (CAHAI 9) Baseline to Follow-up (2 Timepoints)value at 6 weeks minus value at baselineThe change score (Follow-up - Baseline) for the Chedoke Arm and Hand Activity Index 9 is reported. The change score scale ranges 0(min) to 63 (max). Higher scores indicate greater ability. Follow-up is at 6 weeks post treatment cessation. The scale measure bilateral activity performance.

Secondary

MeasureTime frameDescription
Change Score (Value at Follow-up - Value at Baseline) Fugl Meyer Upper Extremity Test of Functionvalue at 6 weeks minus value at baselineChange score between 2-time points (6 weeks follow up - baseline) Change score scale: minimum is 0 and maximum is 66. Higher scores indicate better outcomes.

Countries

United States

Participant flow

Participants by arm

ArmCount
Bilateral Priming
Bilateral priming a priming technique which is non-invasive and free of side effects. The technique described in this study uses bilateral, symmetrical, rhythmic movement bilateral priming and its purpose is to ready the motor cortex for functional limb training. A rocker is used so that the less affected limb can drive the affected one in symmetrical wrist flexion and extension. The priming (15 minutes) will be following by task specific training (45 minutes). Subjects will then have a break (betw. 30-60 minutes) and then repeat the above. Total priming for one day is 30 minutes. Total task specific training for one day is 90 minutes priming and task specific training: This task specific training protocol has been used in several clinical trials.
8
Health Education
The group with no priming will receive stroke related health education via a website from the American Heart Association (15 minutes). They will use their affected hand (as they are able) This will be followed by 45 minutes of the same task specific arm training protocol described in the bilateral priming group. This group will follow the same schedule as above. The health education (15 minutes) will be following by task specific training (45 minutes). Subjects will then have a break (betw. 30-60 minutes) and then repeat the above. Total time on health education website for one day is 30 minutes. Total task specific training for one day is 90 minutes priming and task specific training: This task specific training protocol has been used in several clinical trials.
8
Total16

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up10
Overall StudyWithdrawal by Subject01

Baseline characteristics

CharacteristicBilateral PrimingHealth EducationTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
2 Participants3 Participants5 Participants
Age, Categorical
Between 18 and 65 years
6 Participants5 Participants11 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants0 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
7 Participants8 Participants15 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants1 Participants2 Participants
Race (NIH/OMB)
Black or African American
4 Participants6 Participants10 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
3 Participants1 Participants4 Participants
Region of Enrollment
United States
8 participants8 participants16 participants
Sex: Female, Male
Female
1 Participants2 Participants3 Participants
Sex: Female, Male
Male
7 Participants6 Participants13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 80 / 8
other
Total, other adverse events
0 / 80 / 8
serious
Total, serious adverse events
1 / 80 / 8

Outcome results

Primary

Change Score of Chedoke Arm and Hand Activity Index Nine (CAHAI 9) Baseline to Follow-up (2 Timepoints)

The change score (Follow-up - Baseline) for the Chedoke Arm and Hand Activity Index 9 is reported. The change score scale ranges 0(min) to 63 (max). Higher scores indicate greater ability. Follow-up is at 6 weeks post treatment cessation. The scale measure bilateral activity performance.

Time frame: value at 6 weeks minus value at baseline

Population: individuals who have survived a stroke greater than 6 months prior to enrollment

ArmMeasureValue (MEAN)Dispersion
Bilateral PrimingChange Score of Chedoke Arm and Hand Activity Index Nine (CAHAI 9) Baseline to Follow-up (2 Timepoints)6.69 score on a scaleStandard Deviation 1.2
Health EducationChange Score of Chedoke Arm and Hand Activity Index Nine (CAHAI 9) Baseline to Follow-up (2 Timepoints)5.03 score on a scaleStandard Deviation 1.8
Secondary

Change Score (Value at Follow-up - Value at Baseline) Fugl Meyer Upper Extremity Test of Function

Change score between 2-time points (6 weeks follow up - baseline) Change score scale: minimum is 0 and maximum is 66. Higher scores indicate better outcomes.

Time frame: value at 6 weeks minus value at baseline

Population: individuals who have survived a stroke greater than 6 months prior to enrollment

ArmMeasureValue (MEAN)Dispersion
Bilateral PrimingChange Score (Value at Follow-up - Value at Baseline) Fugl Meyer Upper Extremity Test of Function10 units on a scaleStandard Error 2.5
Health EducationChange Score (Value at Follow-up - Value at Baseline) Fugl Meyer Upper Extremity Test of Function4.3 units on a scaleStandard Error 1.67

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026